Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea
Authors:
Open Access
- 20 August 2019
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 20 (1) , 1-9
Abstract
Endothelial dysfunction is one of the most important early indicators of atherosclerosis in obstructive sleep apnea (OSA) patients. Endothelial cell specific molecules-1 (ESM-1), which is a novel endothelial dysfunction marker that may be linked to cardiovascular disease. We investigated to assess whether circulating ESM-1 levels are correlated with the presence of coronary artery disease (CAD) in patients with OSA. We performed a cross-sectional study in 228 Chinese OSA subjects, including 185 patients with OSA and 43 controls. The Gensini stenosis scoring system was used to assess the severity of CAD. Circulating ESM-1 levels were measured by Human Magnetic Luminex Screening Assay. The associations between circulating ESM-1 levels and CAD were determined by multivariate logistic regression analysis. The association between ESM-1 levels and Gensini scores was determined by multivariate linear regression analysis. CAD patients had significantly higher circulating ESM-1 levels compared with non-CAD patients (1279.01[918.52–1770.71] pg/ml vs 585.46[423.61–812.56] pg/ml, P < 0.001). After adjusting for confounding factors, we found that circulating ESM-1 levels were an independent risk factor for CAD (OR = 1.633/100 pg ESM-1, 95%CI =1.179–2.262, P = 0.003), while circulating ESM-1 levels have no significant correlation with the Gensini score. Furthermore, circulating ESM-1 showed higher discriminatory accuracy in predicting the presence of OSA (AUC:0.910). Circulating ESM-1 might function as a useful biomarker for monitoring the development and progression of CAD in OSA patients.Keywords
Funding Information
- National Natural Science Foundation of China (81870355)
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201605)
- Beijing Medical Project (2016-4)
This publication has 27 references indexed in Scilit:
- ESM‐1 promotes adhesion between monocytes and endothelial cells under intermittent hypoxiaJournal of Cellular Physiology, 2018
- Biomarkers of cardiovascular stress in obstructive sleep apneaClinica Chimica Acta, 2016
- Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular AnginaAngiology, 2016
- Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndromeThe Clinical Respiratory Journal, 2016
- Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association with Coronary Artery Disease in Patients with HypertensionJournal of Investigative Medicine, 2015
- Prevalence and Associated Factors of Obstructive Sleep Apnea in Patients with Resistant HypertensionAmerican Journal of Hypertension, 2014
- Obstructive sleep apnea as a risk factor for coronary events or cardiovascular deathSleep and Breathing, 2009
- Obstructive sleep apnea, immuno-inflammation, and atherosclerosisSeminars in Immunopathology, 2009
- Obstructive Sleep Apnea as a Risk Factor for Stroke and DeathNew England Journal of Medicine, 2005
- ESM-1 Is a Novel Human Endothelial Cell-specific Molecule Expressed in Lung and Regulated by CytokinesJournal of Biological Chemistry, 1996